0001703057-24-000026.txt : 20240227 0001703057-24-000026.hdr.sgml : 20240227 20240227141258 ACCESSION NUMBER: 0001703057-24-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hansen Carl L. G. CENTRAL INDEX KEY: 0001834412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 24685212 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 wk-form4_1709061178.xml FORM 4 X0508 4 2024-02-26 0 0001703057 AbCellera Biologics Inc. ABCL 0001834412 Hansen Carl L. G. C/O ABCELLERA BIOLOGICS INC 2215 YUKON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA 1 1 1 0 Chief Executive Officer 0 Common Shares 2024-02-26 5 M 0 E 56125 2.70 A 729625 D Common Shares 55802493 I See footnote Share option (right to buy) 2.70 2024-02-26 5 M 0 E 56125 0 D 2030-11-27 Common Shares 56125 8428598 D These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person. The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. Tryn Stimart, attorney-in-fact 2024-02-27